Novo Presents Cagrisema Data Ahead of FDA Decision
Published 16 h ago2 sourcesEvidence: Reported
A STAT survey indicates that during July-August 2025, roughly 10% of U.S. adults reported taking a GLP-1 medication in the prior year, reflecting significant uptake of these drugs. The finding underscores the expanding market for GLP-1s beyond diabetes into weight management, with implications for healthcare costs and pharmaceutical demand. The survey is self-reported and may overstate or understate actual use, but it signals a major shift in treatment patterns.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 16 h ago2 sourcesEvidence: Reported
Published 4 h ago1 sourceEvidence: Reported
Published 22 h ago1 sourceEvidence: Reported
Published 13 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 17 h ago2 sourcesEvidence: Reported
Published 12 h ago1 sourceEvidence: Reported